Author(s): Zain ul Abidin,1 Ata ul Haq,2 Kamal ud Din Khan,3 Asma Ilyas,4 Muhammad Ahsan Riaz,5 Moazzam Nazeer Tarar6
Published: 02/08/2021 | Pages: 33-37 |
Tumors involving foot are rare to encounter, challenging to manage, and not adequately addressed in the literature. Many institutes are lacking behind in handling such cases. Our study highlighted the issues faced and elaborated on the steps involved in the management of foot tumors. Objective: To share our experience regarding presentation, management, and functional outcome of foot tumors. Methodology: This was a retrospective case series done at Jinnah Burn and Reconstructive Surgery Centre, Lahore, from January 2017 to April 2020.Eleven patients with foot tumors were retrospectively identified. We reviewed the following details from each patient’s record: Duration of presentation, prior treatments, histological type, grade/stage of the tumor, surgical management, oncological and functional outcome using MSTS (Musculoskeletal tumor society 1987 ). Results: Out of eleven patients, five (45.4% ) were males and six (54.5%) were females, with a mean age of 48 + 11.8 years. The mean duration of postoperative follow-up was 24.3 +7.8 months. Histological diagnosis was Squamous Cell Carcinoma (SCC) (n=4), SCC (Marjolin) (n=2), Melanoma (n=3) and Sarcoma (n=2). All tumors were treated with excision under frozen section control and immediately reconstructed with Split thickness skin graft ( STSG ) in 5 (45.4% ) patients, pedicled medial planter in 2 (18.1%), and free Anterolateral thigh flaps (ALTF) in 2 (18.1%). Limb salvaged in all patients except 2(18.1 %) who need a trans-metatarsal amputation. The MSTS 1987 scores averaged 24.5 +8.6. out of a possible 35 points. Conclusion: Tumors of the foot are rare to encounter but timely referral to specialized center for appropriate treatment results in good functional outcomes.
1. Bakotic, BW, Borkowski P .Primary soft tissue neoplasm of the foot: the clinicopathologic features of 401 cases. J. Foot Ankle Surg. 2001; 28–35.
2. Toepfer A , Harrasser N , Recker M. Lenze U, Pohlig F, Gerdesmeyer, et al. Distribution patterns of foot and ankle tumors: a university tumor institute experience. BMC Cancer.2018; 18, 735
3. Smith J, Mello LF, NogueiraNeto NC, Meohas W, Pinto LW, Campos VA, et al. Malignancy in chronic ulcers and scars of the leg (Marjolin’s ulcer): a study of 21 patients. Skeletal Radiol. 2001;30(6):331-7.
4. Knackfuss IG, Giordano V, Godoy-Santos AL, Fernandes NC, Camargo OP. Squamous cell carcinoma in the foot: Case series and Literature review. ActaOrtop Bras. 2018;26(2):108-11.
5. Kallini JR, Hamed N, Khachemoune A. Squamous cell carcinoma of the skin:epidemiology, classification, management, and novel trends. Int J Dermatol. 2015; 54(2): 130-40.
6. Pekarek B, Buck S and Osher L,A Comprehensive Review on Marjolin’s Ulcers: Diagnosis and Treatment. Journal of the American College of Certified Wound
Specialists .2011 ; (3)60–64
7. Rashid OM, Schaum JC, Wolfe LG, Brinster NK, Neifeld JP. Prognostic variables and surgical management of foot melanoma: Review of a 25-year institutional experience. ISRN Dermatol. 2011; 2011: 384729.
8. Kozawa E, Nishida Y, Nakashima H, Tsukushi S, Toriyama K, Kamei Y, and Ishiguro N. Foot sarcomas: Factors affecting oncological and functional outcomes. Oncol Lett. 2012; 3:82–88.
9. Unni KK. General aspects and data on 10,135 cases. In: Dahlin’s Bone Tumors. 6th edition. Lippincott Williams & Wilkins, Philadelphia, PA, pp1-224, 2010.
10. Ruggieri P, Angelini A, Jorge FD, Maraldi M, Giannini S. Review of foot tumors seen in a university tumor institute. J Foot Ankle Surg. 2014;53(3): 282–5.
11. Kennedy JG, Ross KA, Smyth NA, Hogan MV, Murawski CD. Primary tumors of the foot and ankle. Foot Ankle Spec. 2016;9(1):58–68
12. Giuliano, AE, Eilber FR. The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas. J. Clin. Oncol.1985; 3:1344–1348.
13. Thacker MM, Potter BK, Pitcher JD, Temple HD. Soft tissue sarcomas of the foot and ankle: impact of unplanned excision, limb salvage, and multimodality therapy. Foot Ankle Int .2008;29:690-8.
14. Ali A, Hasan O, Habib A, Umer M. Low cost reconstructive options after musculoskeletal tumor resection in developing countries. Affordable, effective, and durable alternatives J Pak Med Assoc.2019 ;69 (01); 72- 76.
15. Malhotra KP, Shukla S, Husain N, Bhatt ML. Combined Squamomelanocytic Tumor of the Plantar Surface of the Foot: Histogenetic Insights. Am J Derma- to patrol.2016;38(5):396-7.
16. Adams BE, Peng PD, Williams ML. Melanoma of the Foot Is Associated With Advanced Disease and Poorer Survival. The Journal of Foot & Ankle Surgery .2018; 57; 52–55
17. Ramu E, Houdek M T, Isaac C, Dickie C I, Ferguson P, and Wunder J.S. Management of soft-tissue sarcomas; treatment strategies, staging, and outcomes. SICOT J. 2017; 3-20
18. Wallace J. Frozen section methodology. Pathology Outlines.com website. https:// www. pathologyoutlines. com/topic/methodsfrozen.html. 2020.
19. Shaikh WR, Dusza SW,Weinstock MA, Oliveria SA, Geller AC,Halpern AC.Melanoma thickness and survival trends in the United States, 1989-2009. J Natl Cancer Inst .2016; 108:294,
20. Tejera-Vaquerizo A, Nagore E, Puig S, Robert C, Saiag P, Martiń -Cuevas P.et all. Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma.Eur J Cancer .2015 ;51:1780–1793.
All published material becomes the sole property of the Pakistan Journal of Plastic Surgery, copyrighted by the Pakistan Association of Plastic Surgeons (PAPS). By submitting an article or brief communication, all authors agree to these conditions.
During the submission process, all authors have required to complete a copyright transfer agreement, “Author Consent form” By completing the copyright transfer agreement, you are transferring copyright of figures, tables, videos, and the content of the manuscript to the Pakistan Association of Plastic Surgeons (PAPS).
If you do not wish to or cannot transfer copyright of some or all of your content, please contact the editorial office at pjpspakistan@gmail.com